Article
Relationship of CYP2C19*2 and CYP2C19*3 gene polymorphism with clopidogrel response variability and recurrent cardiovascular events in Chinese patients undergoing percutaneous coronary intervention.
Pharmacology - 1 Jan 2013
Liu Yamin, Liu Naifeng, Li Weilan, Shao Hua, Zhi Hong, Li Jie
Abstract excerpt
BACKGROUND/AIMS: The study was conducted to assess the influence of CYP2C19 polymorphisms on clopidogrel response variability and recurrent cardiovascular (CV) events in Chinese patients undergoing percutaneous coronary intervention (PCI). METHODS: Platelet aggregation induced by 5 and 20 µmol/l adenosine diphosphate was measured in 109 patients at baseline, 12 h and 36 h after loading with 300 mg of clopidogrel....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
